Approved external precedentTTR: approved RNAi precedent
TTR is an approved RNAi target-modulation external precedent only. Cellico Bio is not claiming a care program; TTR is an anchored reference node while Cellico Bio maps fragment-level review regions for downstream validation.
refs: dailymed-onpattro-patisiran, dailymed-amvuttra-vutrisiran, fda-rna-based-medicine-patisiran
Cellico Bio computational searchCellico Bio: fragment review-region search
Computational review region; validation required. The overlay marks where source-grounded fragment review sits across somatic and aging-context layers.
refs: No public citation required for schematic overlay
Comparator contextAggregation-context comparators
IAPP, MAPT/tau, amyloid context, aging-context nodes, and oldest-old ATTRwt context orient the fragment-space layer. Optional prion-like context stays muted unless citation-gated.
refs: lehallier_2019, oh_2023, ding_2025_text_only, tanskanen_2008_ssa_very_aged, connors_2011_ssa_men, coles_young_2012_supercentenarian_ttr
Comparator contextOldest-old ATTRwt context
Wild-type transthyretin amyloid is included as a somatic-endpoint context for the oldest old and for male-skewed late-life ATTRwt observations. This is context only, not a Cellico Bio TTR treatment or causality claim.
refs: tanskanen_2008_ssa_very_aged, connors_2011_ssa_men, coles_young_2012_supercentenarian_ttr
Comparator contextRNA accessibility / folding-ensemble context
Exploratory accessibility and folding-ensemble context only. The atlas does not equate RNA accessibility with a protein-state label.
refs: No public citation required for schematic overlay